3
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Inhibition of Bcr Serine Kinase by Tyrosine Phosphorylation

, , , , , , & show all
Pages 998-1005 | Received 18 Aug 1995, Accepted 29 Dec 1995, Published online: 29 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

G. Radziwill, R. A. Erdmann, U. Margelisch & K. Moelling. (2003) The Bcr Kinase Downregulates Ras Signaling by Phosphorylating AF-6 and Binding to Its PDZ Domain. Molecular and Cellular Biology 23:13, pages 4663-4672.
Read now
Xiaowu Zhang, Ramesh Subrahmanyam, Ray Wong, Alec W. Gross & Ruibao Ren. (2001) The NH2-Terminal Coiled-Coil Domain and Tyrosine 177 Play Important Roles in Induction of a Myeloproliferative Disease in Mice by Bcr-Abl. Molecular and Cellular Biology 21:3, pages 840-853.
Read now
Antoni Gayà, Fiorella Pirotto, Eduard Palou, Frank Autschbach, Victoria Del Pozo, Josepa Solé & Carles Sew-Pages. (1999) CD148, a New Membrane Tyrosine Phosphatase Involved in Leukocyte Function. Leukemia & Lymphoma 35:3-4, pages 237-243.
Read now
Kenneth R. LaMontagne$suffix/text()$suffix/text(), Andrew J. Flint, B. Robert Franza$suffix/text()$suffix/text(), Ann Marie Pendergast & Nicholas K. Tonks. (1998) Protein Tyrosine Phosphatase 1B Antagonizes Signalling by Oncoprotein Tyrosine Kinase p210 bcr-abl In Vivo. Molecular and Cellular Biology 18:5, pages 2965-2975.
Read now
X. Y. D. Guo, Jason Font Ana, Donald Kufe & Albert Deisserpth. (1998) Antagonistic Effects of ABL and BCRABL Proteins on Proliferation and the Response to Genotoxic Stress in Normal and Leukemic Myeloid Cells. Leukemia & Lymphoma 30:3-4, pages 225-235.
Read now

Articles from other publishers (29)

George M. Burslem, Anna Reister Schultz, Daniel P. Bondeson, Christopher A. Eide, Samantha L. Savage Stevens, Brian J. Druker & Craig M. Crews. (2019) Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation. Cancer Research 79:18, pages 4744-4753.
Crossref
Camille Malouf & Katrin Ottersbach. (2017) Molecular processes involved in B cell acute lymphoblastic leukaemia. Cellular and Molecular Life Sciences 75:3, pages 417-446.
Crossref
Pedro Alves Bezerra Morais, Renata Dalmaschio Daltoé & Heberth de Paula. (2016) Opening the door to the development of novel Abl kinase inhibitors. Future Medicinal Chemistry 8:17, pages 2143-2165.
Crossref
Isabella Haberbosch, Anahita Rafiei, Claudia Oancea, Oliver Gerhart Ottmann, Martin Ruthardt & Afsar Ali Mian. (2016) BCR: a new target in resistance mediated by BCR/ABL-315I?. Genes & Cancer 7:1-2, pages 36-46.
Crossref
Anahita Rafiei, Afsar Ali Mian, Claudia Döring, Anna Metodieva, Claudia Oancea, Frederic B. Thalheimer, Martin Leo Hansmann, Oliver Gerhard Ottmann & Martin Ruthardt. (2015) The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia. PLOS Genetics 11:4, pages e1005144.
Crossref
A-Reum Park, Daeyoung Oh, So-Hee Lim, Jeonghoon Choi, Jeonghee Moon, Dae-Yeol Yu, Sung Goo Park, Nora Heisterkamp, Eunjoon Kim, Pyung-Keun Myung & Jae-Ran Lee. (2012) Regulation of dendritic arborization by BCR Rac1 GTPase-activating protein, a new substrate of protein tyrosine phosphatase receptor T. Journal of Cell Science.
Crossref
A Samanta, B Perazzona, S Chakraborty, X Sun, H Modi, R Bhatia, W Priebe & R Arlinghaus. (2010) Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia. Leukemia 25:3, pages 463-472.
Crossref
B Perazzona, H Lin, T Sun, Y Wang & R Arlinghaus. (2007) Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects. Oncogene 27:15, pages 2208-2214.
Crossref
Stephane WongOwen N. Witte. (2004) The BCR-ABL Story: Bench to Bedside and Back. Annual Review of Immunology 22:1, pages 247-306.
Crossref
Hiroshi Katayama, Kaori Sasai, Hidehiko Kawai, Zhi-Min Yuan, Jolanta Bondaruk, Fumio Suzuki, Satoshi Fujii, Ralph B Arlinghaus, Bogdan A Czerniak & Subrata Sen. (2003) Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genetics 36:1, pages 55-62.
Crossref
Ralph Arlinghaus & Tong Sun. 2004. Molecular Targeting and Signal Transduction. Molecular Targeting and Signal Transduction 239 270 .
Asit K Chakraborty & Salil K Das. (2003) Molecular cloning and characterization of the guinea pig cholinephosphotransferase gene. Biochemical and Biophysical Research Communications 312:4, pages 1104-1110.
Crossref
Tong Sun & Ralph B. Arlinghaus. (2003) Preparation and Application of Polyclonal and Monoclonal Sequence‐Specific Anti‐Phosphoamino Acid Antibodies. Current Protocols in Protein Science 34:1.
Crossref
Hanno Steen, Minerva Fernandez, Saghi Ghaffari, Akhilesh Pandey & Matthias Mann. (2003) Phosphotyrosine Mapping in Bcr/Abl Oncoprotein Using Phosphotyrosine-specific Immonium Ion Scanning. Molecular & Cellular Proteomics 2:3, pages 138-145.
Crossref
Richard A Van Etten. (2002) Studying the pathogenesis of BCR–ABL+ leukemia in mice. Oncogene 21:56, pages 8643-8651.
Crossref
Ralph B Arlinghaus. (2002) Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia. Oncogene 21:56, pages 8560-8567.
Crossref
Aparajita Ghosh, Jacqueline Akech, Shyamali Mukherjee & Salil K Das. (2002) Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells. Biochemical and Biophysical Research Communications 297:4, pages 1043-1048.
Crossref
Ming Tan, Tong Jing, Keng-Hsueh Lan, Christopher L Neal, Ping Li, Sangkyou Lee, Dexing Fang, Yoichi Nagata, Jiaxin Liu, Ralph Arlinghaus, Mien-Chie Hung & Dihua Yu. (2002) Phosphorylation on Tyrosine-15 of p34Cdc2 by ErbB2 Inhibits p34Cdc2 Activation and Is Involved in Resistance to Taxol-Induced Apoptosis. Molecular Cell 9:5, pages 993-1004.
Crossref
Feng Lin, Giuseppe Monaco, Tong Sun, Jiaxin Liu, Hui Lin, Clifton Stephens, John Belmont & Ralph B Arlinghaus. (2001) BCR gene expression blocks Bcr-Abl induced pathogenicity in a mouse model. Oncogene 20:15, pages 1873-1881.
Crossref
Yoshiro Maru. (2001) Molecular Biology of Chronic Myeloid Leukemia. International Journal of Hematology 73:3, pages 308-322.
Crossref
Katharina Pachmann, Shourong Zhao, Thomas Schenk, Hagop Kantarjian, Adel K. El-Naggar, Michael J. Siciliano, Jie-Qiang Guo, Ralph B. Arlinghaus & Michael Andreeff. (2001) Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification . British Journal of Haematology 112:3, pages 749-759.
Crossref
Tong Sun, Martin Campbell, William Gordon & Ralph B. Arlinghaus. (2001) Preparation and application of antibodies to phosphoamino acid sequences. Biopolymers 60:1, pages 61-75.
Crossref
Michael W. N. DeiningerJohn M. GoldmanJunia V. Melo. (2000) The molecular biology of chronic myeloid leukemia. Blood 96:10, pages 3343-3356.
Crossref
Michael W. N. DeiningerJohn M. GoldmanJunia V. Melo. (2000) The molecular biology of chronic myeloid leukemia. Blood 96:10, pages 3343-3356.
Crossref
E Laurent, M Talpaz, M Wetzler & R Kurzrock. (2000) Cytoplasmic and nuclear localization of the 130 and 160 kDa Bcr proteins. Leukemia 14:11, pages 1892-1897.
Crossref
Victoria del Pozo, Fiorella Pirotto, Blanca Cárdaba, Isabel Cortegano, Soledad Gallardo, Marta Rojo, Ignacio Arrieta, Esther Aceituno, Pilar Palomino, Antoni Gaya & Carlos Lahoz. (2000) Expression on human eosinophils of CD148: a membrane tyrosine phosphatase. Implications in the effector function of eosinophils. Journal of Leukocyte Biology 68:1, pages 31-37.
Crossref
Yun Wu, Guozhen Ma, Dai Lu, Feng Lin, Hong-Ji Xu, Jiaxin Liu & Ralph B Arlinghaus. (1999) Bcr: a negative regulator of the Bcr-Abl oncoprotein. Oncogene 18:31, pages 4416-4424.
Crossref
Paris A Skourides, Samanthi A Perera & Ruibao Ren. (1999) Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins. Oncogene 18:5, pages 1165-1176.
Crossref
Jianze Li & Thomas E. Smithgall. (1996) Co-expression with BCR Induces Activation of the FES Tyrosine Kinase and Phosphorylation of Specific N-terminal BCR Tyrosine Residues. Journal of Biological Chemistry 271:51, pages 32930-32936.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.